```html

Urticaria – Physical (Dermatographic)

Overview

Urticaria, commonly known as hives, is a skin reaction that produces red, raised, itchy welts. Physical urticaria refers to a subgroup where the hives are triggered by a specific physical stimulus rather than an allergen. The most frequent form of physical urticaria is dermatographic urticaria (also called “skin writing”). In dermatography, light scratching or pressure on the skin causes a linear, raised, reddened rash that typically lasts 15–30 minutes but can persist for hours.

• Who it affects: Adults of any age can develop dermatographic urticaria, but it is most common in women (≈ 60 % of cases) and in individuals aged 20–40 years.
• Prevalence: Physical urticaria accounts for 20–30 % of all chronic urticaria cases. Dermatographic urticaria alone affects approximately 0.5–1 % of the general population, according to epidemiological data from the United Kingdom and the United States.<sup>1</sup>
• Course: In most people the condition is chronic (lasting > 6 weeks) but benign. Symptoms may wax and wane, often improving with age.

Symptoms

Symptoms of dermatographic urticaria are triggered by mechanical forces on the skin. A typical episode follows a predictable pattern:

• Linear wheals: Raised, red or flesh‑colored lines that appear within minutes of scratching, stroking, or applying pressure. The length matches the area of contact.
• Itching or burning sensation: Varies from mild pruritus to a more intense burning feeling.
• Duration: Individual wheals usually fade within 15–30 minutes, but new lesions can continue to form if the stimulus persists.
• Swelling (angio‑edema): In up to 20 % of patients, deeper tissues (lips, eyelids, hands) may swell.
• Systemic symptoms: Rare, but some individuals report mild headache, light‑headedness, or low‑grade fever during severe outbreaks.

Because the rash is provoked by mechanical contact, the appearance can be highly variable—linear, circular, or even “honey‑comb” patterns—depending on the shape of the stimulus.

Causes and Risk Factors

Dermatographic urticaria is considered an autoimmune or idiopathic disorder of mast cells. The exact mechanism is not fully understood but involves the following pathways:

• Mast‑cell degranulation: Physical pressure causes mast cells in the dermis to release histamine, leukotrienes, and prostaglandins, leading to vasodilation and edema.
• Auto‑antibodies: In 30–40 % of chronic physical urticaria patients, IgG auto‑antibodies against the high‑affinity IgE receptor (FcεRI) or IgE itself have been identified.<sup>2</sup>
• Underlying disorders: Thyroid disease (especially autoimmune thyroiditis), hepatitis C, and systemic lupus erythematosus have been linked to higher rates of physical urticaria.

Risk factors

• Female sex (≈ 60 % of cases).
• Family history of chronic urticaria or other atopic conditions.
• Existing autoimmune disease (e.g., Hashimoto thyroiditis).
• Stress and hormonal fluctuations—symptoms often worsen during menstrual cycles or pregnancy.
• Use of certain medications that increase histamine release (e.g., NSAIDs, ACE inhibitors).

Diagnosis

Diagnosis is primarily clinical, based on history and physical examination. The following steps are typically performed:

1. Detailed history: Onset, pattern of lesions, triggers (scratching, tight clothing, pressure), duration, and any systemic symptoms.
2. Physical examination: The clinician may perform a standardized “scratch test” using a wooden tongue depressor or a blunt instrument. A single linear wheal that appears within 5–10 minutes confirms dermatographic urticaria.
3. Rule‑out other conditions:
   • Allergic contact dermatitis (requires patch testing).
   • Vasculitic lesions (biopsy shows leukocytoclastic vasculitis).
   • Infections or drug reactions.
4. Laboratory tests (optional): Baseline CBC, ESR, and thyroid function tests are often ordered to screen for systemic disease.
5. Additional specialty testing: In refractory cases, a dermatologist may order a skin biopsy or serum auto‑antibody panels.

Treatment Options

Therapy aims to control symptoms, prevent new wheals, and improve quality of life. Treatment is typically stepped‑wise, following the same approach used for chronic spontaneous urticaria.

1. Antihistamines (first‑line)

• Second‑generation H1 blockers: Cetirizine, loratadine, fexofenadine, or desloratadine are preferred because they cause less sedation.
• Standard dose is taken once daily; for persistent symptoms, the dose may be increased up to four‑fold under physician supervision (e.g., cetirizine 20 mg daily).<sup>3</sup>

2. First‑generation antihistamines (short‑term)

Diphenhydramine or hydroxyzine can be used at night for breakthrough itching, but their sedative effects limit daytime use.

3. Leukotriene receptor antagonists

• Montelukast 10 mg nightly may be added if antihistamines alone are insufficient.
• Evidence from randomized trials shows modest improvement in a subset of patients with physical urticaria.<sup>4</sup>

4. Omalizumab (anti‑IgE monoclonal antibody)

For chronic cases unresponsive to high‑dose antihistamines, omalizumab 300 mg subcutaneously every 4 weeks has demonstrated > 70 % response rates in clinical trials.<sup>5</sup>

5. Systemic corticosteroids (short courses)

Prednisone 10–20 mg daily for ≤ 2 weeks can break severe flares, but long‑term use is discouraged due to side effects.

6. Non‑pharmacologic measures

• Cold compresses: Applied for 5–10 minutes can reduce itching.
• Loose clothing: Prevents pressure‑induced wheals.
• Skin moisturizers: Thick, fragrance‑free emollients maintain barrier function.

Living with Urticaria—Physical (Dermatographic)

While dermatographic urticaria is not life‑threatening for most people, the constant itching and visible wheals can affect daily activities and emotional well‑being.

Practical tips

• Identify personal triggers: Keep a brief diary noting activities, clothing, and stress levels that precede a flare.
• Gentle skin care: Use hypoallergenic soaps, avoid hot showers (which increase skin permeability), and pat skin dry instead of rubbing.
• Protect pressure points: Pad elbows, knees, and the back of the neck with soft fabrics.
• Stress management: Techniques such as mindfulness, yoga, or CBT have been shown to lower urticaria activity scores.<sup>6</sup>
• Medication adherence: Take antihistamines daily even on “symptom‑free” days to maintain mast‑cell stability.
• Travel considerations: Carry rescue antihistamine tablets, a small bottle of cold pack, and a written summary of your diagnosis for medical personnel.

Emotional health

Chronic urticaria can lead to anxiety or depression in up to 30 % of patients.<sup>7</sup> If mood changes arise, discuss them with your primary care provider; referral to a mental‑health professional is often helpful.

Prevention

Because the condition is triggered by physical stimuli rather than a modifiable exposure, “prevention” focuses on minimizing provocation:

• Wear soft, breathable fabrics (cotton, bamboo) and avoid tight belts or compression garments.
• Trim fingernails short to reduce inadvertent scratching.
• Apply a thin layer of barrier cream (e.g., petrolatum) before activities that involve friction (e.g., backpack straps).
• Maintain a healthy weight—excess pressure on skin folds can increase episodes.
• Limit or avoid known medication triggers (NSAIDs, certain antibiotics) when possible.

Complications

When left untreated or poorly managed, dermatographic urticaria may lead to:

• Persistent itching: Can cause excoriations, secondary bacterial infection, and scarring.
• Angio‑edema: Swelling of deeper tissues may impair airway patency in rare, severe cases.
• Sleep disturbance: Nighttime itching reduces sleep quality, contributing to fatigue and mood disorders.
• Psychosocial impact: Social embarrassment, reduced work productivity, and increased health‑care utilization.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. Hives (Urticaria) – Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/hives/symptoms-causes/syc-20354973
2. Kolkhir P, et al. Auto‑immune mechanisms in chronic urticaria. Allergy. 2017;72(12):1926‑1935. https://doi.org/10.1111/all.13224
3. Cleveland Clinic. Urticaria (Hives) Treatment. https://my.clevelandclinic.org/health/diseases/15256-hives-urticaria
4. Maller O, et al. Montelukast add‑on therapy for chronic urticaria. J Dermatol Treat. 2014;25(3):215‑221. https://doi.org/10.3109/09546634.2013.857718
5. Maurer M, et al. Omalizumab for chronic urticaria. NEJM. 2013;368:924‑934. https://doi.org/10.1056/NEJMoa1401412
6. CDC. Stress and coping – Tips for managing stress. https://www.cdc.gov/mentalhealth/stress-coping/cope-with-stress.html
7. Zhu W, et al. Psychological comorbidities in chronic urticaria patients. J Clin Psychol Med Settings. 2019;26(3):458‑466. https://doi.org/10.1007/s10880-019-09669-4

```